Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors

Increasing demand for glutaminase (GLS) due to high rates of glutamine metabolism is considered one of the hallmarks of malignancy. In parallel, cancer antigen 125 (CA‐125) is a commonly used ovarian tumor marker. This study aimed to compare the roles of GLS and CA‐125 in distinguishing between beni...

Descripción completa

Detalles Bibliográficos
Autores principales: Winarno, Gatot Nyarumenteng Adhipurnawan, Effendi, Jusuf Sulaeman, Harsono, Ali Budi, Salima, Siti, Darwizar, Bagja Dumas, Sasotya, R. M. Sonny, Rachmawati, Anita, Mulyantari, Ayu Insafi, Trianasari, Nurvita, Handono, Budi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651661/
https://www.ncbi.nlm.nih.gov/pubmed/37526308
http://dx.doi.org/10.1111/cts.13603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651661/
https://www.ncbi.nlm.nih.gov/pubmed/37526308
http://dx.doi.org/10.1111/cts.13603

Ejemplares similares